| Literature DB >> 18606713 |
Nienke Vrisekoop1, Rogier van Gent, Anne Bregje de Boer, Sigrid A Otto, Jan C C Borleffs, Radjin Steingrover, Jan M Prins, Taco W Kuijpers, Tom F W Wolfs, Sibyl P M Geelen, Irma Vulto, Peter Lansdorp, Kiki Tesselaar, José A M Borghans, Frank Miedema.
Abstract
It remains uncertain whether full T cell reconstitution can be established in HIV-infected children and adults with long-term sustained virological control by highly active antiretroviral therapy (HAART). In this study, we comprehensively analyzed various phenotypical markers of CD4 T cell recovery. In addition to measuring T cell activation and proliferation markers, CD4 T cell generation and aging of the CD4 T cell compartment were assessed by measuring TCR excision circles and the fraction of CD31-expressing naive CD4 T cells. In all children and in adults with relatively high CD4 T cell counts at start of therapy (>200 cells/microl), total CD4 T cell numbers normalized within 1 year of therapy. After long-term HAART (4.4-9.6 years), naive CD4 T cell counts had normalized in both groups. Although in adults with low baseline CD4 T cell counts (<200 cells/microl) total CD4 T cell numbers normalized eventually after at least 7 years of HAART, naive CD4 T cell counts had still not recovered. TCR excision circle data showed that thymic T cell production contributed to naive T cell recovery at all ages. The fraction of CD31-expressing naive CD4 T cells was found to be normal, suggesting that the CD4 T cell repertoire was diverse after long-term HAART. Hence, under sustained viral suppression during long-term HAART, the T cell compartment has the potential to fully recover by generating new naive T cells both in children and in adults with high baseline CD4 T cells counts. Irrespective of baseline CD4 T cell counts, reconstitution occurred without a significant effect on T cell aging as reflected by markers for replicative history.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18606713 DOI: 10.4049/jimmunol.181.2.1573
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422